Isabel L. Virella-Lowell, MD
Pulmonology and Sleep Medicine
Locations
About Me
Professor, Co-Director, UAN Therapeutics Development Network; Medical Director, Pediatric Pulmonary Care Unit, Titles: Professor Co-Director, CF Therapeutics Development Network Center Co-Director, Airways Clinical Research Center Co-Director Pediatric Pulmonary Clinical Research Program Medical Director of 10Q Pediatric Pulmonary Care Unit
Education
Residency:
University of Florida
, Pediatrics
Medical School:
Medical Univeristy of South Carolina
Internship:
University of Florida
UnderGraduate:
Duke University
Board Certifications
Pediatrics, American Board of Pediatrics (1970)
American Board of Pediatrics - Pediatric Pulmonology (1970)
Languages
Portuguese
Spanish
Honors and Awards
Best Doctors in America
Interests
Professional Organizations
Society for Pediatric Research, American Academy of Pediatrics, American Thoracic Society
Publications
PUBLICATIONS: https://www.ncbi.nlm.nih.gov/pubmed/?term=virella-lowell%2C+i 1.Urte Sommerwerck, Isabel Virella-Lowell, Gerhild Angyalosi Andrea Viegas, Weihua Cao, Laurie Debonnett. Long-term Safety of Tobramycin Powder for Inhalation in Cystic Fibrosis Patients: Results from a Phase IV (ETOILES) Study. Curr Med Res Opin. 2016 Jul 20:1-2 2. S Morrow Buff, H Yu, J McCall, S Caldwell, T Ferkol, T Flotte, and I Virella-Lowell. IL-10 delivery by adeno-associated vector attenuates inflammation in mice with Pseudomonas pneumonia. Gene Ther. 2010 May;17(5):567-76. 3. H Yu, Y Zeidan, B Wu, T Flotte, Y Hannun, and I Virella-Lowell. Loss of induction of acid sphingomyelinase is associated with persistent pseudomonas aeruginosa infection in cystic fibrosis. Am J Respir Cell Mol Biol. (2009) Jan 23. 4. Jennifer L Wentzel, MS, Isabel Virella-Lowell, MD, Zachary M. Soler, MD, MSc. Quantitative sinonasal symptom assessment in an unselected pediatric population with cystic fibrosis. Am J Rhinol Allergy. 2015 Sep-Oct;29(5):357-61. 5. sabel Virella-Lowell, Amy Poirier, Kye A. Chesnut, Mark Brantly, and Terence R. Flotte. Inhibition of Recombinant Adeno-associated Virus (rAAV) Transduction by Bronchial Secretions From Cystic Fibrosis Patients. Gene Ther 2000. 7(20)1783-1789.
Professor, Co-Director, UAN Therapeutics Development Network; Medical Director, Pediatric Pulmonary Care Unit, Titles: Professor Co-Director, CF Therapeutics Development Network Center Co-Director, Airways Clinical Research Center Co-Director Pediatric Pulmonary Clinical Research Program Medical Director of 10Q Pediatric Pulmonary Care Unit
Honors and Awards
Best Doctors in America
Additional Resources
Interests
Professional Organizations
Society for Pediatric Research, American Academy of Pediatrics, American Thoracic Society
Publications
PUBLICATIONS: https://www.ncbi.nlm.nih.gov/pubmed/?term=virella-lowell%2C+i 1.Urte Sommerwerck, Isabel Virella-Lowell, Gerhild Angyalosi Andrea Viegas, Weihua Cao, Laurie Debonnett. Long-term Safety of Tobramycin Powder for Inhalation in Cystic Fibrosis Patients: Results from a Phase IV (ETOILES) Study. Curr Med Res Opin. 2016 Jul 20:1-2 2. S Morrow Buff, H Yu, J McCall, S Caldwell, T Ferkol, T Flotte, and I Virella-Lowell. IL-10 delivery by adeno-associated vector attenuates inflammation in mice with Pseudomonas pneumonia. Gene Ther. 2010 May;17(5):567-76. 3. H Yu, Y Zeidan, B Wu, T Flotte, Y Hannun, and I Virella-Lowell. Loss of induction of acid sphingomyelinase is associated with persistent pseudomonas aeruginosa infection in cystic fibrosis. Am J Respir Cell Mol Biol. (2009) Jan 23. 4. Jennifer L Wentzel, MS, Isabel Virella-Lowell, MD, Zachary M. Soler, MD, MSc. Quantitative sinonasal symptom assessment in an unselected pediatric population with cystic fibrosis. Am J Rhinol Allergy. 2015 Sep-Oct;29(5):357-61. 5. sabel Virella-Lowell, Amy Poirier, Kye A. Chesnut, Mark Brantly, and Terence R. Flotte. Inhibition of Recombinant Adeno-associated Virus (rAAV) Transduction by Bronchial Secretions From Cystic Fibrosis Patients. Gene Ther 2000. 7(20)1783-1789.
